Table 1. Patients’ baseline characteristics.
| Characteristics | Values |
|---|---|
| Number of patients | 20 |
| Age | 58.95±5.47 |
| Gender (M/F) | 16 [80]/4 [20] |
| ECOG performance status, n [%] | |
| 0 | 12 [60] |
| 1 | 5 [25] |
| 2 | 3 [15] |
| BCLC stage, n [%] | |
| A | 2 [10] |
| B | 15 [75] |
| C | 3 [15] |
| Tumor size (cm), n [%] | |
| ≤5 | 8 [40] |
| >5 | 12 [60] |
| ALT (U/L) | 57.50 (44.25–83.25) |
| AST (U/L) | 76.65±23.51 |
| Albumin (g/dL) | 2.85 (2.70–3.30) |
| Total bilirubin (mg/dL) | 1.84±0.77 |
| AFU (U/L) | 610 (502.5–755.25) |
| IL-10 (pg/mL) | 35.79±9.54 |
Data are expressed as mean ± SD for Gaussian variables, median (inter-quartile range) for non-Gaussian variables and frequencies [percentages] for categorical variables. ECOG, Eastern Cooperative Oncology Group; BCLC, Barcelona Clinic Liver Cancer; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AFU, alpha-L-fucosidase; IL-10, interleukin-10.